Financing in Medtech: An Overview

In recent years, the medical technology (medtech) industry has attracted significant attention from investors and companies alike, driven by ongoing innovation. In this article, utilizing the data Biotechgate has to offer on the medtech field, you’ll find an overview of how funding in the industry has developed, including a review of the past and what’s … Continue reading Financing in Medtech: An Overview

Read more

Medtech Categorization in Biotechgate Explained

The Medical Technology (medtech) category is one of the six core company sectors in the Biotechgate database. Read our brief overview on what exactly this area consists of and how we define companies that fall under the medtech umbrella. Based on our categorization system, medtech companies are defined as those involved in the research, development, … Continue reading Medtech Categorization in Biotechgate Explained

Read more

5 Medtech Start-Ups to Watch in 2024

Given that the majority of startups in the medtech industry fail in the long run, with 60% of startups not surviving the first five years according to recent studies, it is particularly interesting to keep an eye on the successful start-ups that have performed well in the recent past. Here is a list of five … Continue reading 5 Medtech Start-Ups to Watch in 2024

Read more

Top 10 Largest Financing Rounds in 2023

In what could be termed as a cautious year, there was still plenty of financing round activity in the life sciences industry. Based on Biotechgate data, these are the top 10 rounds sorted by the amount raised. Notably, private equity rounds have not made the cut for the list. 10. Vaxcyte View on Biotechgate » … Continue reading Top 10 Largest Financing Rounds in 2023

Read more

The 5 Largest Life Science M&A Deals of 2023

Despite uncertainties continuing from 2022 into 2023, the year saw a wide range of deals take place spanning across the industry. This article will highlight the top 5 deals that were completed throughout 2023. 5. Biogen and Reata Pharmaceuticals Deal value: USD 7.3 billion Date completed: July 2023 Biogen emerged victorious in a bidding war … Continue reading The 5 Largest Life Science M&A Deals of 2023

Read more

How AI is Transforming Healthcare

Artificial Intelligence has emerged as an integral force in the global digital health industry, transforming the way healthcare data is analyzed and diseases are diagnosed. AI and machine learning hold the promise of delivering more personalized and accessible healthcare. In this article, we will have a deeper look into some of the innovations AI technology … Continue reading How AI is Transforming Healthcare

Read more

6 AI-Driven Companies to Watch

Artificial intelligence (AI) is being rapidly integrated by life science companies seeking to reduce costs, become more efficient and enhance their automation, with this process only being spurred on by the COVID-19 pandemic. In this article, we’ve put together a list of companies to keep an eye on, with their operations centered on AI. 1.     … Continue reading 6 AI-Driven Companies to Watch

Read more

How Biotechgate Uses Artificial Intelligence

At Biotechgate, we provide you with a comprehensive life sciences database, allowing users access to up-to-date information covering companies, licensing deals, financing rounds and more. We use a unique data-sourcing process to gather large amounts of information across the entire biopharma industry, giving Biotechgate users access to unprecedented information – thanks, in part, to artificial … Continue reading How Biotechgate Uses Artificial Intelligence

Read more

The Current State of M&A Activity in the Life Sciences Industry

The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the … Continue reading The Current State of M&A Activity in the Life Sciences Industry

Read more

Life Sciences M&A Report: Half-Year 2023

In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains … Continue reading Life Sciences M&A Report: Half-Year 2023

Read more